<DOC>
	<DOCNO>NCT00706563</DOCNO>
	<brief_summary>This study design test immunogenicity reactogenicity Fluarix™/Influsplit SSW® influenza vaccine contain influenza strain recommend 2008-2009 season .</brief_summary>
	<brief_title>A Study Evaluation Immunogenicity Reactogenicity Fluarix™ / Influsplit SSW® 2008/2009 Adults</brief_title>
	<detailed_description />
	<criteria>Subjects investigator believe comply requirement protocol enrol study . A male female age 18 year time vaccination . Written inform consent obtain subject . Healthy subject wellcontrolled chronic disease establish medical history clinical examination enter study . If subject female , must nonchildbearing potential childbearing potential , must practice adequate contraception 30 day prior vaccination , negative pregnancy test continue precaution 2 month completion vaccination series Use investigational nonregistered product ( drug vaccine ) study vaccine ( ) within 30 day precede vaccination plan use study period . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug within six month prior vaccine dose . Administration immunoglobulins and/or blood product within three month precede administration study vaccine plan study . Administration influenza vaccine within 1 year precede study start . Administration influenza vaccine study vaccine entire study Clinically virologically confirm influenza infection within 1 year precede study start History allergic disease reaction likely exacerbate component vaccine . Acute disease time enrolment . Acute clinically significant pulmonary , cardiovascular , hepatic renal functional abnormality , determine physical examination laboratory screen test . Not stabilize clinically serious chronic underlying disease . Lactating female . History chronic alcohol consumption and/or drug abuse . Any confirm suspected immunosuppressive immunodeficient condition , base medical history physical examination . Any condition , opinion investigator , prevents subject participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>